Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the <i>HGF</i>/<i>PTEN</i>/<i>Wnt</i>/β-catenin axis

Abstract

Melatonin could potentially enhance osteogenic differentiation of BMSCs and retard bone loss through the <i>HGF</i>/<i>PTEN</i>/<i>Wnt</i>/β-catenin axis.